Total Payments
$359.84
2022 Payments
$254.12
Companies
7
Transactions
22
Medicare Patients
843
Medicare Billing
$98,400
Payment Breakdown by Category
Food & Beverage$359.84 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $359.84 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vifor Pharma, Inc. | $95.48 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $82.12 | 5 | $0 (2022) |
| Amgen Inc. | $80.48 | 4 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $45.19 | 2 | $0 (2022) |
| Travere Therapeutics, Inc. | $24.94 | 4 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $18.60 | 1 | $0 (2021) |
| Horizon Therapeutics plc | $13.03 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $254.12 | 16 | Vifor Pharma, Inc. ($80.17) |
| 2021 | $105.72 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($21.72) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $4.76 | General |
| 11/17/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $3.76 | General |
| 11/09/2022 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Hyperkalemia | ||||||
| 10/20/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Nephrology | ||||||
| 09/14/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.97 | General |
| 09/14/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $2.45 | General |
| 09/01/2022 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Hyperkalemia | ||||||
| 08/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardio-renal | ||||||
| 08/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Nephrology | ||||||
| 06/29/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Hyperkalemia | ||||||
| 05/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Nephrology | ||||||
| 01/26/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Hyperkalemia | ||||||
| 12/14/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: KRYSTEXXA | ||||||
| 11/17/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Nephrology | ||||||
| 11/08/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Cardio-renal | ||||||
| 09/22/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Nephrology | ||||||
| 03/23/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 12 | $1,668 | $824.40 |
| 2022 | 3 | 249 | 297 | $64,517 | $29,676 |
| 2021 | 3 | 244 | 283 | $58,084 | $28,543 |
| 2020 | 6 | 338 | 409 | $101,281 | $39,357 |
Total Patients
843
Total Services
1,001
Medicare Billing
$98,400
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,668 | $824.40 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 236 | $37,524 | $18,797 | 50.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 32 | 42 | $18,585 | $8,263 | 44.5% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 15 | 19 | $8,408 | $2,616 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 224 | $35,616 | $17,929 | 50.3% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 34 | 43 | $19,028 | $8,672 | 45.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 16 | $3,440 | $1,941 | 56.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 218 | 244 | $38,796 | $16,489 | 42.5% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 60 | 98 | $43,365 | $16,201 | 37.4% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 22 | 29 | $12,833 | $3,681 | 28.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 11 | 11 | $4,868 | $2,173 | 44.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 12 | $785.00 | $471.58 | 60.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 15 | 15 | $635.00 | $340.80 | 53.7% |
About Deanna Campbell, FNP
Deanna Campbell, FNP is a Family healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093918096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deanna Campbell, FNP has received a total of $359.84 in payments from pharmaceutical and medical device companies, with $254.12 received in 2022. These payments were reported across 22 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($359.84).
As a Medicare-enrolled provider, Campbell has provided services to 843 Medicare beneficiaries, totaling 1,001 services with total Medicare billing of $98,400. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Olathe, KS
- Active Since 06/07/2007
- Last Updated 05/05/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1093918096
Products in Payments
- Veltassa (Drug) $95.48
- FARXIGA (Drug) $82.12
- Parsabiv (Drug) $80.48
- Kerendia (Drug) $45.19
- Auryxia (Drug) $18.60
- KRYSTEXXA (Biological) $13.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Olathe
Mrs. Jessica Molstad, Np, NP
Family — Payments: $7,586
Family $7,586
Mrs. Heather Conklin, Arnp, ARNP
Family — Payments: $5,196
Family $5,196
Amanda Morris, N.p, N.P
Family — Payments: $4,234
Family $4,234
Christine Smith, Aprn, APRN
Family — Payments: $4,017
Family $4,017
Courtni Parker, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $2,348
Family $2,348
Tarryn Gardner
Family — Payments: $1,868
Family $1,868